Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today

Core Insights - Collegium Pharmaceutical's shares increased by 11.6% following the announcement of strong Q3 2025 financial results, surpassing analyst expectations and raising full-year guidance [1][2] Financial Performance - The company reported net revenue of $209.4 million, reflecting a year-on-year increase of 31.4%, which exceeded Wall Street forecasts [2] - Collegium raised its full-year net revenue forecast to a range of $775 million to $785 million and adjusted EBITDA projection to between $460 million and $470 million [2] Market Reaction - The stock's movement indicates low volatility, with only 9 instances of greater than 5% movement in the past year, suggesting significant market impact from the recent news [4] - The stock has risen 44.5% year-to-date, reaching a new 52-week high of $41.36 per share [6] - An investment of $1,000 in Collegium shares five years ago would now be valued at $2,105 [6]